Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (152)

2024

  1. Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy—A Hospital-Based Prospective Observational Study

    Journal of Clinical Medicine, Vol. 13, Núm. 4

  2. Impact of an Evidence-Based Prioritization System and Electronic Consultation in Early Diagnosis of Colorectal Cancer

    Healthcare (Switzerland), Vol. 12, Núm. 2

  3. Time-restricted eating and supervised exercise for improving hepatic steatosis and cardiometabolic health in adults with obesity: protocol for the TEMPUS randomised controlled trial

    BMJ Open, Vol. 14, Núm. 1

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis

    Pharmacological Research, Vol. 195

  3. Beneficial Effects of Limosilactobacillus fermentum in the DCA Experimental Model of Irritable Bowel Syndrome in Rats

    Nutrients, Vol. 15, Núm. 1

  4. Binging from Food to Alcohol: A Sequential Interaction Between Binging Behaviors in Male Wistar Rats

    Bio-protocol, Vol. 13, Núm. 15

  5. Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020

    American journal of clinical oncology, Vol. 46, Núm. 10, pp. 433-438

  6. Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

    Human Genomics, Vol. 17, Núm. 1

  7. Editorial: Molecular mechanisms underlying obesity and their links with other comorbidities

    Frontiers in Molecular Biosciences

  8. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  9. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players

    Pathogens, Vol. 12, Núm. 7

  10. Human adipose tissue as a major reservoir of cytomegalovirus-reactive T cells

    Frontiers in Immunology, Vol. 14

  11. Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication—A Systematic Review

    Journal of Clinical Medicine, Vol. 12, Núm. 15

  12. Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice

    Frontiers in Pharmacology, Vol. 14

  13. The Antioxidant Properties of Lavandula multifida Extract Contribute to Its Beneficial Effects in High-Fat Diet-Induced Obesity in Mice

    Antioxidants, Vol. 12, Núm. 4

  14. The Antioxidant Properties of Salvia verbenaca Extract Contribute to Its Intestinal Antiinflammatory Effects in Experimental Colitis in Rats

    Antioxidants, Vol. 12, Núm. 12

  15. The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer

    Metabolites, Vol. 13, Núm. 6

  16. Tigecycline reduces tumorigenesis in colorectal cancer via inhibition of cell proliferation and modulation of immune response

    Biomedicine and Pharmacotherapy, Vol. 163

  17. Vitamin B12: For more than just the treatment of megaloblastic anemia?

    Revista Clinica Espanola, Vol. 223, Núm. 2, pp. 114-119